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Abstract
Background: During early stages of brain development, secreted molecules, components of intracellular signaling
pathways and transcriptional regulators act in positive and negative feed-back or feed-forward loops at the mid-
hindbrain boundary. These genetic interactions are of central importance for the specification and subsequent
development of the adjacent mid- and hindbrain. Much less, however, is known about the regulatory relationship
and functional interaction of molecules that are expressed in the tectal anlage after tectal fate specification has
taken place and tectal development has commenced.
Results: Here, we provide experimental evidence for reciprocal regulation and subsequent cooperation of the
paired-type transcription factors Pax3, Pax7 and the TALE-homeodomain protein Meis2 in the tectal anlage. Using
in ovo electroporation of the mesencephalic vesicle of chick embryos we show that (i) Pax3 and Pax7 mutually
regulate each other’s expression in the mesencephalic vesicle, (ii) Meis2 acts downstream of Pax3/7 and requires
balanced expression levels of both proteins, and (iii) Meis2 physically interacts with Pax3 and Pax7. These results
extend our previous observation that Meis2 cooperates with Otx2 in tectal development to include Pax3 and Pax7
as Meis2 interacting proteins in the tectal anlage.
Conclusion: The results described here suggest a model in which interdependent regulatory loops involving Pax3
and Pax7 in the dorsal mesencephalic vesicle modulate Meis2 expression. Physical interaction with Meis2 may then
confer tectal specificity to a wide range of otherwise broadly expressed transcriptional regulators, including Otx2,
Pax3 and Pax7.
Background
Progressive regionalization events subdivide the early
developing neural tube into a series of distinct units,
which are marked by the expression of specific combi-
nations of transcriptional regulators and signaling mole-
cules. Expression of many of these proteins broadly
overlaps at early embryonic stages, but progressively
restricts later in embryogenesis due to a series of posi-
tive and negative regulatory events. This leads to the
generation of molecularly defined territories, which sub-
sequently differentiate into anatomically and functionally
different brain structures. A well-studied example for
such regionalization events is the development of the
mesencephalic alar plate, the anlage of the optic tectum
in non-mammalian vertebrates or of the superior
colliculus in mammals. The optic tectum develops from
the caudal most part of the dorsal aspect of Otx2
expression domain. Otx2 expression is an essential pre-
requisite for the development of all anterior brain struc-
tures, which is evident in the lack of fore- and midbrain
derived structures in Otx2 mutant mice [1-3]. Tectal
development is tightly linked to the activity of the mid-
hindbrain boundary (MHB) organizer, a group of cells
located at the junction between the mesencephalic and
metencephalic vesicles. Cells of the MHB organizer
secrete long-range and short-range signaling molecules,
which are necessary and sufficient for the development
of the adjacent mid- and hindbrain structures [4].
Transplantation of the MHB region into the diencepha-
lon, mesencephalon or rhombencephalon elicits the
ectopic expression of mid-/hindbrain markers and the
formation of ectopic polarized mesencephalic and cere-
bellar structures surrounding the graft [5-8]. This activ-
ity can be mimicked by local application of Fgf8, a
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secreted protein normally expressed within the MHB
organizer territory [9,10]. Induction and maintenance of
Fgf8 expression and MHB organizer activity depends on
multileveled genetic interactions of transcription factors
and signaling molecules, which include (among others)
the secreted molecules Wnt1, Wnt3a and Wnt10b, the
nuclear proteins Pax2/3/5/7/8, En1, En2, and Lmx1b, all
of which act in positive feedback loops with Fgf8 [4].
Conversely, feedback antagonists of Fgf8 signaling such
as Sef, Spry1, Spry2 and Mkp3 confine the organizer
activity to a narrow ring of cells at the mid-hindbrain
junction [4]. Positive and negative autoregulation thus
shapes and maintains the MHB organizer.
Two transcription factors reported to contribute to
MHB organizer maintenance are the paired-box tran-
scription factors Pax3 and Pax7 [11,12]. Both proteins
share extensive homologies in protein sequence and
expression patterns and are therefore believed to have
arisen from a gene duplication event [13]. The impor-
tance of Pax3 in dorsal neural tube and neural crest pat-
terning and differentiation is evident in the human
syndromes associated with Pax3 mutations (Waarden-
burg syndromes type I and type III) as well as in mouse
Splotch mutants. By contrast, Pax7 mutant mice do not
display major defects in central nervous system develop-
ment, which suggests a significant degree of functional
overlap of the two Pax proteins [14,15]. In fact, knock-
in of Pax7 can rescue the central nervous system and
neural crest defects associated with the Pax3/Splotch
mutant phenotype [16]. In chick embryos, Pax3 and
Pax7 are expressed from the ten somite stage onwards
in nested domains within the dorsal neural tube. By the
25-26 somite stage, mesencephalic Pax3 expression
extends more ventrally than that of Pax7, whereas only
Pax7 expression reaches rostrally into the telencephalic
vesicle [[11]; and Figure 1). Although expression of both
genes is not specific for the mid-hindbrain territory,
ectopic expression of either one induced expression of
MHB organizer associated genes including Fgf8 and En2
and elicited development of ectopic tectal structures
[11].
We have previously reported a pivotal role for Meis2
in tectal development [17]. Meis2 belongs to the TALE
(three amino acid loop extension) class of homeodomain
containing proteins, which function as regulators of cell
proliferation and differentiation of various tissues and
organs during development. Meis family proteins form
dimeric and trimeric complexes with other transcription
factors, including the closely related Pbx family, mem-
bers of the HOX clusters, several other homeodomain
containing proteins and some basic helix-loop-helix
(bHLH) proteins [18]. Mesencephalic Meis2 expression
commences around the 19-20 somite stage and thus
later than Pax3 and Pax7. Within the mesencephalic
vesicle, Meis2 is largely confined to the tectal anlagen
with sharp expression boundaries to the diencephalon
and the MHB territory [17]. Meis2 is both necessary and
sufficient for tectal development: introduction of a
Figure 1 Meis2, Pax3 and Pax7 are expressed in nested domains in the HH15-19 chick midbrain. (A-G) Expression of Meis2 (A, D), Pax3 (B,
E) and Pax7 (C, F) as detected by in-situ hybridization on HH15 whole chick embryos (A-C) or neighboring vibratome cross sections through a
HH19 mesencephalic vesicle (D-F). (G) Schematic summary of the expression patterns. di: diencephalic vesicle; le: lens; mes: mesencephalic
vesicle; met: metencephalic vesicle; rt: retina. The arrows in (D-F) mark the ventral border of the respective expression domains. Panel (D) was
taken from [17].
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function blocking form of Meis2 into the mesencephalic
vesicle abolishes normal tectal development, whereas a
single, transient transfection of Meis2 in the diencepha-
lic vesicle triggers the development of ectopic tectal
structures. Meis2 lies downstream of Fgf8 in the hierar-
chy of tectum inducing genes, autoregulates its own
expression and thereby stabilizes tectal fate [17,19]. The
underlying mechanism, however, is only partially under-
stood. One unique feature of Meis2 is its ability to
induce a di- to mesencephalic fate change without any
noticeable induction of Fgf8 expression. Instead, Meis2
directly interacts with Otx2 and competes with the
Groucho co-repressor protein Tle4 for binding to Otx2,
thereby releasing Otx2 from Tle4 mediated repression
[17]. Whether Meis2 also associates with transcriptional
regulators of tectal development other than Otx2 and
what molecules regulate Meis2 expression levels within
the mesencephalic alar plate is not known yet. This is
important, since Meis2 autostimulates its own expres-
sion in the tectal anlage [17]. Some restraint needs
therefore to be in place to prevent exuberant autoactiva-
tion of Meis2. So far, the nature of any inhibitory activ-
ity on Meis2 expression within the developing optic
tectum remained elusive.
Here, we report a series of gain of function and bio-
chemical experiments performed in chick embryos,
which suggest that i) ectopic Pax7 expression induces
Pax3, ii) elevated expression levels of Pax3 reduce
expression of Pax7 and Meis2, but at different concen-
trations, which suggests Meis2 expression requires a
specific concentration threshold of Pax3 and Pax7, and
iii) both paired domain proteins form heteromeric com-
plexes with Meis2. These results show that interdepen-
dent regulatory loops involving Pax3, Pax7 and Meis2
exist in the tectal anlage and argue for a more general
role of Meis2 as co-factor of different transcriptional
regulators of tectal development.
Results
Meis2, Pax3 and Pax7 are expressed in nested territories
in the tectal anlage
A hallmark of early mid-/hindbrain fate specification is the
mutual cross-regulation of proteins, which are expressed
across the MHB organizer. Much less is known, however,
about genetic interactions that may occur in the tectal
anlage after initial fate specification has taken place. As a
first step, we therefore compared the expression domains
of Pax3, Pax7 and Meis2. Consistent with previous
reports, we detected Pax3 and Pax7 transcripts at Ham-
burger Hamilton (HH) stage 15 (24-27 somites) in the alar
plates of the spinal cord, and of the met-, mes- and dien-
cephalic vesicles extending anteriorly to include pro-
somere 1 (Figure 1B, C, G) [11,20-24]. Pax7 was
additionally expressed along the telencephalic midline. In
contrast, Meis2 expression was absent from the met-, di-
and telencephalon, but strongly expressed in the mesence-
phalic vesicle (Figure 1A, G) [17]. One day later, at HH19
(37-40 somites), Pax3, Pax7 and Meis2 transcripts were
still abundant in the tectal anlage, as in-situ hybridization
on adjacent vibratome sections showed (Figure 1D-F).
Overexpression of Pax7 induces Pax3 but represses
Meis2- and ephrin-B1
To investigate a possible relationship between Pax3 and
Pax7 in the midbrain, we ectopically delivered an
expression plasmid carrying Pax7 together with GFP
(pMES-Pax7) by in ovo electroporation into the right
lateral wall of the mesencephalic vesicle at HH9-HH11
(7-13 somite stage, Figure 2A). Due to the shot-gun nat-
ure of this gene delivery method, random patches of
GFP expression, indicative of groups of cells forced to
express the GFP and Pax7 transgenes, were seen across
the right mesencephalic wall (Figure 2A, B”). Consistent
with a previous report, we found that in these patches
Pax3 expression was strongly induced as early as 16
hours following Pax7 misexpression (HH14, n = 15/19
GFP expressing specimens exhibited strong ectopic
Pax3 expression following electroporation of 2 μg/μl
pMES-Pax7 (79%); Figure 2B, B’, C) [11]. Robust upre-
gulation of Pax3 expression was still visible 24 hours
and 36 hours after pMES-Pax7 transfection (HH18 and
HH21 respectively, Figure 2D and data not shown).
Ectopic Pax3 expression was also observed when Pax7
misexpression was specifically targeted to the ventral
midbrain (n = 8/14 GFP positive specimens exhibited
ectopic Pax3 expression after targeted Pax7 expression
into the ventral mesencephalic vesicle (57%); Figure 2E).
Scattered groups of cells expressing elevated levels of
Pax3 transcripts were not only located within the terri-
tory of the endogenous Pax3 domains, but also reached
ventrally towards the Nkx6.1 expression domain (Figure
2B’, E’). A comparison of Figure 2B’ and Figure 2B“
revealed that apparently not all Pax7-GFP positive cells
also express Pax3 mRNA, especially not in the ventral
midbrain. This may be due to the short incubation time
of the embryos after electroporation (HH9-11 to HH14)
and may thus reflect incomplete upregulation of Pax3
by Pax7. In addition, gene delivery by in ovo electro-
poration causes targeted cells to take up varying
amounts of DNA. Considering that ectopic induction of
Pax3 may need a certain threshold of Pax7 protein
(especially in the ventral neural tube, where Sonic hedge-
hog signaling promotes the induction of ventral cell fates
[25,26]), it is possible that the ectopic Pax7 levels may
not have reached the threshold necessary for Pax3
induction in all GFP-positive cells. In any case however,
ectopic Pax3 expressing cells in the ventral mesencepha-
lon were consistently positive for Pax7.
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Two lines of evidence from our previous study suggested
that Meis2 may not act upstream, but rather downstream
of or in parallel to Pax3 and Pax7: (i) electroporation of a
function blocking form of Meis2 into the mesencephalic
vesicle had not affected Pax3 or Pax7 expression and (ii)
ectopic delivery of Meis2 into the diencephalon was not
sufficient to induce expression of either Pax gene (Figure
S4 of [17]). To explore a reciprocal relationship of the
three proteins, we assessed Meis2 expression following
Pax7 misexpression. Contrary to our initial expectation,
Meis2 specific transcripts were reduced in the midbrain
vesicle after forced expression of Pax7 compared to
embryos transfected with GFP alone, (n = 7/9 embryos
exhibited reduced Meis2 expression following electropora-
tion of 2 μg/μl pMES-Pax7 (78%); Figure 3A, B-B”, E).
Likewise, expression of ephrinB1 (efnb1), a downstream
target of Meis2 in the tectal anlage, was also diminished in
Pax7 electroporated embryos (n = 5/7 (71%); Figure 3C,
D-D’, E) [17]. Thus, although all three genes are co-
expressed within the tectal anlage, elevating Pax7 expres-
sion levels increased Pax3 but repressed Meis2 expression
under identical experimental conditions.
Midbrain Meis2- and Pax7 expression are repressed by
Pax3 in a dose dependent manner
To further explore this apparent contradiction, we ecto-
pically expressed a HA-tagged form or Pax3 (pMIWIII-
Pax3-HA) in the mesencephalic vesicle. Meis2 expression
was generally not affected following electroporation of
concentrations between 0.1 to 1 μg/μl of the Pax3
expressing plasmid (n = 0/7 embryos exhibited reduced
Meis2 expression following electroporation of 0.1 μg/μl
pMIWIII-Pax3-HA (0%); n = 1/8 following electropora-
tion of 0.5 μg/μl (13%); n = 0/8 following electroporation
of 1 μg/μl (0%); Figure 4A, B, G). In contrast, transfection
of 2 μg/μl of pMIWIII-Pax3-HA effectively repressed
Meis2 transcripts (n = 13/14 (93%); Figure 4C, G). Elec-
troporation of 2 μg/μl of pMIWIII-Pax3-HA also
repressed efnb1 expression (n = 7/9 (78%), Figure 4D).
Notably, Pax7 specific transcripts were lost in the dorsal
midbrain already at a concentration of 1 μg/μl pMIWIII-
Pax3-HA (1 μg/μl: n = 6/7 (86%); 2 μg/μl: n = 8/10 (80%);
Figure 4E, F, G and data not shown). Thus, Pax7, like
Meis2, is negatively regulated by Pax3, but repression of
Pax7 occurs already at half the concentration of the Pax3
expressing plasmid required to repress Meis2 or its
downstream gene efnb1. In summary, these results sug-
gest that Pax7 induces Pax3 and Pax3 represses Pax7 in
the dorsal midbrain leading to tightly balanced expres-
sion levels of both proteins, which in turn are permissive
for expression of Meis2 and its target gene efnb1.
Meis2-Pax3 and Meis2-Pax7 containing protein complexes
exist in the tectal anlage
As we reported previously, Meis2 forms heteromeric
complexes with Otx2 in the tectal anlage and binding to
Figure 2 Pax7 induces Pax3 expression in the mesencephalic vesicle. (A) Representative example of pMES-Pax7 electroporation into the
mesencephalic vesicle. GFP expression, indicative of transgene expression, is restricted to the right half of the neural tube 4-6 hours later. (B-B“)
Flat mount preparation of a HH14 chick neural tube, 16 hours after electroporation of 2 μg/μl pMES-Pax7 into the mesencephalic vesicle; Pax3
expression is in dark blue, Nkx6.1 expression in pink, GFP in green. The dotted lines mark the dorso-ventral boundary, the arrow heads indicate
representative examples of ectopic Pax7 positive cells co-expressing Pax3. Ectopic patches of Pax3 expression are restricted to the right,
electroporated half of the mesencephalic vesicle. (B’) is a higher magnification of (B) with the GFP fluorescent image superimposed onto the
preparation. (B“) shows the distribution of Pax7-GFP expressing cells in the specimen shown in (B’). (C) Quantification of the results: percent
specimens with induced (green bars) and unaltered (blue bars) Pax3 expression following targeted electroporation of pMES-Pax7. (D) Flat mount
preparation of a HH18 chick neural tube, 24 hours after electroporation of 2 μg/μl pMES-Pax7. (E) Targeted misexpression of pMES-Pax7 into the
ventral mesencephalic vesicle showing cells ectopically expressing Pax3 within the Nkx6.1 domain. (E’) is a higher magnification of (E). fb:
forebrain; fp: floor plate; mes: mesencephalic vesicle; met: metencephalic vesicle; ov: optic vesicle; otv: otic vesicle. Scale bar (B, B’): 100 μm.
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Meis2 is necessary for Otx2 to induce ectopic tectal
development upon misexpression in the metencephalic
alar plate [17]. Based on these observations and because
of the two proteins only Meis2 expression is specific for
the prospective optic tectum (Otx2 is present in the
entire neural tube anterior of the MHB), we had sug-
gested that complex formation with Meis2 may confer
tectal specificity to Otx2 in the dorsal midbrain, where
both transcription factors are co-expressed. Pax3 and
Pax7 can also trigger ectopic tectal development when
misexpressed [11]. However, like for Otx2, their expres-
sion is not specific for the tectal anlage, but includes the
alar plate along most of its length [11]. We therefore
decided to examine whether Meis2 may interact with
Pax3 or Pax7 in the dorsal mesencephalic vesicle. In
GST-pull down experiments using a GST-tagged form
of Meis2 and protein extracts prepared from HH 15-18
chick mesencephalic vesicle Pax3 and Pax7 readily preci-
pitated with Meis2-GST but not with GST alone. Pax3
and Pax7 can thus associate with recombinant Meis2
(Figure 5A, left half, top and bottom panels). When
Meis2-specific antibodies were used to precipitate endo-
genous Meis2-containing protein complexes Pax3 and
Pax7 were successfully enriched in the precipitates. Iso-
type-specific control antibodies, however, were not suc-
cessful (Figure 5A, right half, top and bottom panels).
Precipitation of Pax7 was significantly reduced when a
truncated form of Meis2 lacking the MEINOX domain
fused to GST (Meis2[199-400], ΔMD) was used and com-
pletely abolished when a truncated form lacking the
homeodomain fused to GST (Meis2[1-190], ΔHD; Figure
5B, C) was used.
To confirm that both truncated forms are active, we
tested them for their ability to bind to the PBC class
homeodomain protein Pbx1, a known Meis interacting
partner, or to DNA respectively. Meis proteins bind to
PBC class proteins via their MEINOX domain, a bipar-
tite protein interaction domain located N-terminal of
the homeodomain (Figure 5B) [27]. Accordingly, full
length Meis2 and Meis2ΔHD successfully precipitated
Pbx1b, whereas Meis2ΔMD and GST were ineffective
(Figure 5D). Meis family proteins recognize variations of
the consensus sequence motif 5’-TGATA(A/G)-3’ in the
regulatory regions of target genes [28]. Although Meis
proteins frequently cooperate with PBC class proteins in
binding to DNA, examples of Pbx independent DNA
binding are also known [29]. We therefore performed
electromobility shift assays (EMSA) with purified Meis2-
GST fusion proteins and a 32P-labeled oligonucleotide
probe, which was previously shown to be bound by
Meis independently of Pbx [29]. Complex formation of
the probe was observed with full-length Meis2 and
Meis2ΔMD but not with Meis2ΔHD or GST alone (Fig-
ure 5E). Excess of a non-labeled specific oligonucleotide
effectively competed for full length Meis2 or Meis2ΔMD
DNA binding (Figure 5E and data not shown).
GST-fusion proteins lacking the amino acids N-terminal
to the MEINOX domain (Meis2[64-400]ΔN) or Meis2 lack-
ing the transactivation domain, which is located C-term-
inal to the homeodomain (Meis2[1-338]ΔC), also effectively
Figure 3 Pax7 represses Meis2 and efnb1 in the mesencephalic vesicle. (A-B“) Meis2 expression in HH15 chick embryos electroporated with
2 μg/μl of a control vector carrying only GFP (A) or 2 μg/μl pMES-Pax7 (B, B“) into the right wall of the mesencephalic vesicle. The insert in (A)
shows a higher magnification and continuous expression of Meis2 in the control embryo. (B’) is a higher magnification of the boxed area in (B).
Arrowheads point to patches of cells with reduced Meis2 transcripts. In (B”) the GFP fluorescence of the specimen shown in (B and B’) is
superimposed to visualize the extent of Pax7/GFP transfection. (C-D’) efnb1 expression in a HH15 chick embryo transfected with a control vector
(C) or with pMES-Pax7 (D, D’) under identical experimental conditions. (D’) is a higher magnification of (D). (E) Quantification of the results:
percent specimens with reduced (red bars) and unaltered (blue bars) Meis2 or efnb1 expression following targeted electroporation of pMES-Pax7.
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precipitated Pax3 and Pbx1b (Figure 5F) [17,30]. We
therefore conclude that the MEINOX domain and homeo-
domain of Meis2 are involved in the association with Pax3
and Pax7. Complex formation between Meis2 and Pax7
was also seen when an antibody specific for Pax7 was used
in the immunoprecipitation experiments (Figure 5G). The
relatively weak Meis2-specific band in the IP with the
Pax7-specific antibody compared to the robust co-precipi-
tation of Pax7 with the Meis2-specific antibody may indi-
cate that only a fraction of the Meis2 protein present in
the extracts is bound to Pax7 (compare immunoprecipi-
tate with a-Meis2 in Figure 5A (upper right panel) and
immunoprecipitate with Δ-Pax7 in Figure 5G). To test
whether Meis2 forms multimeric complexes with Pax7
and Otx2, we re-probed the blot with an antibody directed
against Otx2 (Figure 5H). Contrary to Meis2, Otx2 was
not detected in the immunoprecipitate. We were also not
able to precipitate Pax7 with an Otx2 specific antibody
(data not shown). Although we cannot rule out that the
antibodies used in our precipitation experiments may, to
different extents, interfere with the ability of their antigens
to engage in multiprotein interactions, our results argue
against the existence of large multimeric complexes invol-
ving Meis2, Otx2 and Pax7. Instead, we propose that
Meis2 may form heteromeric complexes with either Pax3
or Pax7 or Otx2 in the dorsal mesencephalic vesicle.
Discussion
Based on in ovo electroporation and immunoprecipita-
tion experiments in chick embryos, we here provide
Figure 4 Dose-dependent repression of Meis2, efnb1 and Pax7 by Pax3. (A-C) Meis2 expression in HH15 embryos electroporated with
indicated concentrations of pMIWIII-Pax3. Loss of Meis2 transcripts can be seen in random patches of the electroporated right half of the
mesencephalic vesicle only after transfection of 2 μg/μl of pMIWIII-Pax3 (C). (D) Loss of efnb1 transcripts following transfection of 2 μg/μl
pMIWIII-Pax3. (E, F) Pax7 expression in the mesencephalic vesicle upon transfection of 1 μg/μl (E) and 2 μg/μl (F) pMIWIII-Pax3. The boxed areas
in (B, E) are shown at a higher magnification in the upper right corners of the respective panels. (G) Quantification of the results: percent
specimens with reduced (red bars) and unchanged (blue bars) expression of Meis2 (left) or Pax7 (right) following electroporation of different
concentrations of pMIWIII-Pax3.
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experimental evidence for reciprocal regulation and sub-
sequent physical interaction of Pax3, Pax7 and Meis2 in
the tectal anlage.
Dose-dependent and reciprocal regulation of Pax3 and
Pax7 in the tectal anlage
Interdependent regulation between Pax3 and Pax7 has
been reported in other physiological contexts before.
Pax7 transcripts, for instance, are upregulated in the
embryonic dorsal spinal cord of Splotch mice, a natu-
rally occurring mutant of Pax3, suggesting that in
mouse spinal cord Pax3 normally functions to repress
Pax7 [14]. In Xenopus laevis embryos, on the other
hand, expression of Pax7 and Pax3 in the neural tube
and neural crest strikingly differs from that in mice and
chicks, which indicates different functional specifications
of both genes in amphibians compared to mammals and
birds [12]. Indeed, Morpholino-mediated knock down of
Pax3 or misexpression of a function blocking form of
Pax3 reduced Pax7 transcript levels in the Xenopus
spinal cord, suggesting that Pax3 positively regulates
Pax7 in amphibians [12]. Although species specific dif-
ferences obviously exist, in summation these results
argue for interdependent regulation of Pax3 and Pax7
in the spinal cord. The observations reported in the pre-
sent study extend this reciprocal regulation of both Pax
Figure 5 Meis2 containing protein complexes in the mesencephalic vesicle. (A) Co-precipitation of Pax3 and Pax7 with Meis2 in GST-pull
down (left panels) and immunoprecipitation experiments using a Meis2 specific antibody (right panels). Upper panel: Western Blot with an
antibody directed against Pax7; lower panel: Western Blot against Pax3. (B) Schematic representation of the Meis2 deletions N-terminally fused to
GST that were used in (A, C, D, E, and F). (C) Pull down experiments using full length Meis2 (Meis2[1-400]), Meis2 lacking the MEINOX-domain
(Meis2[199-400]; ΔMD) or Meis2 lacking the homeodomain (Meis2[1-190]; ΔHD) probed for Pax7. (D) GST-pull down with full length Meis2, ΔMD, ΔHD
and GST probed for Pbx1b. (E) Specific DNA complex formation on a 26-bp oligonucleodite and purified GST proteins. Complex formation is
competed by specific oligomers at a 10×-molar ratio (’competitor’). The sequence of the 23P-labeled oligomer is indicated below. (F) GST-pull
down with ΔN and ΔC probed for Pax3 (upper panel) and Pbx1b (lower panel). (G) Immunoprecipitation using a Pax7-specific antibody probed
for Meis2. (H) The same blot as in (G) stripped and re-probed for Otx2. Cyto: cytoplasmic extract; In: input; IP: immunoprecipitate; no Ab:
precipitation with protein G sepharose beads omitting the antibody; nucl: nuclear extract; PD: pull down; sup: supernatant; wash: final wash step
of the precipitates; WB: Western blot: The asterisks in (A) and (C) mark unspecific bands
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proteins to the embryonic mesencephalon and point to
a possible dose-dependent function of Pax3 during tec-
tal development. Since Pax3 and Pax7 are closely
related and forced expression of either molecule in the
diencephalon leads to identical cell fate changes, Pax3
and Pax7 were suggested to play redundant functions
during tectal development [11,31]. The cross-regulation
between Pax3 and Pax7 we report here may allow for a
tight, mutual regulation of both gene products, which
prevents over-activation of shared downstream pathways
and at the same time permits functional compensation
if one of the genes is mutated.
Examples for dose dependent functions of transcrip-
tional regulators are well known in invertebrate develop-
ment. In the early D. melanogaster embryo, for instance,
spatial gradients of transcription factors control the
expression of distinct sets of target genes, which ulti-
mately control morphogenesis [32-34]. Similar dose
dependent activities have also been reported for tran-
scription factors that engage in reciprocal regulation.
Oligodendrocyte differentiation in the embryonic verte-
brate spinal cord, for instance, depends on the con-
certed activities of Olig2, Sox11 and Nkx2.2. This
process not only requires mutual regulation of the three
proteins but also depends on the gene dosage of Olig2,
as both haploinsufficiency and overexpression of Olig2
significantly delayed oligodendrocyte maturation [35].
Dosage dependent developmental defects also exist for
the paired-type transcription factor Pax6 in both human
and mice [36,37]. Mice heterozygote for PAX6 (Sey,
small eye) display ocular defects with small eyes and
malformations of the anterior eye chamber, as do mice
carrying multiple copies of a PAX6-containing YAC
(yeast artificial chromosome) [38-40]. The underlying
mechanism of such dosage dependent requirement of
transcriptional regulators is only partially understood at
present. One evident explanation takes into account that
transcription factors frequently function in the context
of larger multiprotein complexes, which involve other
DNA binding proteins as well as transcriptional co-regu-
lators that modulate chromatin dynamics. Since the stoi-
chiometry of these transcriptional complexes must be
tightly controlled, too much or too little of any given
component may disturb the formation of functional
complexes and consequently result in insufficient tran-
scriptional activity. Changing the intracellular concentra-
tion of individual transcription factors into either
direction may therefore adversely affect expression of
their target genes and ultimately lead to similar develop-
mental defects.
An intriguing second explanation of how the net acti-
vation of an enhancer can be directly linked to different
concentrations of a given transcription factor comes
from studies of transcription factor gradients in early D.
melanogaster embryos. Here, the bicoid protein binds
individual recognition sites in the regulatory region of
its target gene hunchback with different affinities. This
ensures that high-affinity binding sites can already be
bound and activated by low concentrations of the pro-
tein, whereas high bicoid levels are needed to activate
low-affinity sites [41]. Likewise, Rowan and colleagues
recently reported that the PAX6 lens enhancer was
synergistically regulated by multiple Prep1 proteins,
each non-cooperatively bound to a low-affinity binding
site [42]. Both examples provide a mechanism of how
different concentrations of a given transcription factor
can be directly translated into the net activity of a target
enhancer. Pax3 may therefore directly modulate Pax7
and Meis2 expression, potentially by binding to target
sides in the enhancers of each gene that differ in their
relative affinity for Pax3 (Figure 6A, dashed lines). A
detailed comparison of the midbrain-specific regulatory
regions of Meis2 and Pax7 would be needed to test this
hypothesis. However, although upstream regulatory ele-
ments of Pax7 have been identified, none of them faith-
fully recapitulates expression in the mesencephalic alar
plate and Meis2 enhancer elements have remained elu-
sive so far [43]. Nevertheless it is worth pointing out
that recognition sequences with different binding affi-
nities for Pax3 have been identified in vitro and that dif-
ferences in the affinity of Pax3 to these sites mediate
varying levels of transactivation [44].
Alternatively, Pax3 and Pax7 may control Meis2
expression indirectly (Figure 6A, solid lines). This model
takes into account that both Pax proteins were shown
to trigger expression of MHB associated genes,
Figure 6 Model for a possible cooperation of Meis2, Pax3, Pax7
and Otx2during tectal development. See text for details. Red
lines indicate negative regulation, green arrows positive regulation.
Dashed lines indicate hypothetical direct regulation of the Meis2
promoter/enhancer by different Pax3 concentrations. Solid lines
indicate indirect regulation of Meis2 expression via Pax3/7 mediated
induction of Fgf8 as previously reported: (1) Regulation of Meis2
expression in response to Ras-MAPK signaling levels reported in [19];
(2) Induction of Fgf8 by Pax3 and Pax7 reported in [11]; (3)
Existence of Meis2-Otx2 containing protein complexes in the tectal
anlage reported in [17].
Agoston et al. BMC Developmental Biology 2012, 12:10
http://www.biomedcentral.com/1471-213X/12/10
Page 8 of 12
including Fgf8, when ectopically expressed in the ante-
rior neural tube [11]. We have previously found that
Meis2 transcriptional activation requires low levels of
Ras-MAPK pathway activity that are characteristic for
the mesencephalic vesicle, but is inhibited by strong
Ras-MAPK signals, which induce metencephalic fate
specification [19]. Hence, Pax3 and Pax7 might impinge
on Meis2 expression indirectly through modulating Fgf8
expression levels (and consequently the resulting
strength of Ras-MAPK pathway activation) at the MHB
organizer. Irrespective of whether Pax3 and Pax7 act
directly or indirectly on Meis2 expression, interdepen-
dent and balanced expression of both paired proteins
may serve to prevent excessive autoactivation of Meis2
in the tectal anlage.
Multiple transcriptional regulators associate with Meis2 in
the tectal anlage
Functional subdivision of the brain is preceded by the
restricted expression of transcriptional regulators at
neural tube stages. The anlagen of the optic tecta, origi-
nating from the alar plates of the mesencephalic vesicle,
for instance are characterized by the combinatorial
expression of Otx2, Pax3, Pax7, and Meis2 (Figure 6B).
Notably, all four proteins can instruct tectal fate when
ectopically delivered to the alar plate of adjacent brain
vesicles, but only Meis2 expression faithfully demarcates
the prospective optic tecta. Otx2 expression encom-
passes the entire neural tube anterior of the MHB and
Pax3 and Pax7 are present in the alar plates along most
of the neural tubes anterior-posterior axis [11,17,45].
As we demonstrated previously, Meis2 forms hetero-
meric complexes with Otx2 in the mesencephalon and
association with Meis2 can restore full transcriptional
activity of Otx2 in the presence of the co-repressor Tle4
in an Otx2 dependent reporter assay [17]. This observa-
tion prompted us to suggest that Meis2 may act as tec-
tum-specific cofactor of Otx2. We can now extend this
observation to include Pax3 and Pax7. Association of
Meis2 with Pax3 and Pax7 was observed in vitro and
endogenous Meis2-Pax containing protein complexes
could be precipitated from tectal tissue. Notably how-
ever, we failed to detect interaction of Pax7 and Otx2,
suggesting that Meis2 forms individual complexes with
each of these proteins.
The identification of Meis2-Pax containing nuclear
complexes has also implications for the general concept
of TALE-HD protein function. All Pax proteins except
Pax4 and Pax6 contain an octapeptide motif, a con-
served stretch of eight amino acids related to the eh1
domain. The eh1 domain mediates transcriptional
repressor activity through recruitment of co-repressors
of the Tle/Grg family. Indeed, Pax3 can directly associ-
ate with Grg4 or other transcriptional co-repressors and
has been implicated in transcriptional repression in sev-
eral physiological contexts [46-48]. The Meis2 - Pax3/7
interaction reported here suggests that Meis2 can be
part of transcriptional activator as well as repressor
complexes. In this context it is worth noting that tectal
fate specification not only requires the activation of tec-
tum specific genes, but also the repression of competing
cellular fates. Indeed, Meis2 is not only positively regu-
lates the expression of tectum associated genes such as
efnb1 or Dbx1, but also represses the diencephalic mar-
ker gene Pax6 [17].
Conclusion
We have previously shown that the TALE-homeodomain
protein Meis2 acts downstream of the MHB organizer
and controls tectal development by cooperating with
Otx2. The results described here expand this view and
suggest that tectal Meis2 expression levels are modulated
by Pax3 and Pax7 and that the expression levels of both
Pax proteins have to be tightly balanced to allow for
expression of Meis2. In addition, we find that Meis2 not
only associates with Otx2 in dorsal mesencephalic vesicle
but also with Pax3 and Pax7. Meis2 is the only known
transcriptional regulator so far that is able to instruct tec-
tal fate specification and whose expression specifically
marks the tectal anlage at mid to late somite stages. We
therefore propose that spatially controlled association
with Meis2 may serve as a general mechanism to confer
tectal specificity to a wide range of otherwise broadly
expressed transcription factors.
Methods
Expression constructs, in ovo electroporation
Full length coding regions of Pax3 and Pax7 were
cloned by RT-PCR from total RNA of HH16-20 chick
optic tecta (primer sequences available upon request)
and corresponded to NCBI Acc# NM_204269 (Pax3)
and NCBI Acc# NM_205065 (Pax7) respectively. To
generate pMIWIII-Pax3-HA, the coding region of chick
Pax3 was fused to a triple HA tag and cloned into the
chick expression vector pMIWIII [49]. Full length Pax7
was subcloned into pMES, which contains an IRES-
eGFP (internal ribosome entry site - enhanced green
fluorescent protein) cassette to allow Pax7 expression
together with GFP, resulting in pMES-Pax7 [50]. Unless
otherwise noted, 2 μg/μl of each construct were electro-
porated into the right wall of the neural tube of HH 9-
11 chick embryos as described (White Leghorn) [22,51].
In the case of pMIWIII 0.5 μg/μl pMIWIII-GFP, expres-
sing enhanced green fluorescent protein, was co-electro-
porated for visualization. pMIWIII-GFP or pMES served
as controls. All experiments involving fertilized chick
eggs were performed in accordance with the guidelines
of the local animal care committee.
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In-situ hybridization
In-situ hybridization on vibratome sections or whole
embryos was performed as described in [22,51]. The
cDNAs used to generate in-situ probes for Meis2, efnb1,
Pax3, Pax7, and Nkx6.1 were gifts from D. O’Leary
(Salk Institute, La Jolla, CA, USA), H. Rohrer (Max
Planck Institute for Brain Research, Frankfurt, Ger-
many), P. Gruss (Max Planck Institute for Biophysical
Chemistry, Göttingen, Germany), J. Rubenstein (UCSF,
San Francisco, CA, USA) or were cloned from chick
HH10-12 whole head total RNA by RT-PCR with gene
specific primers (primer sequences are available upon
request).
Isolation and analysis of Meis2 interacting proteins
Preparation of tectal lysates
Approximately 30 HH15-18 chick tecta per experiment
were lysed in 10 mM Hepes pH8, 10 mM KCl, 0.1 mM
EDTA, 2 mM DTT, 1% Igepal (Sigma Aldrich, Ger-
many), and Complete™ protease inhibitor tablets
(Roche, Germany). Cell nuclei were collected by brief
centrifugation. The supernatant contained the cytosolic
fraction (’cyto’). The cell nuclei were reconstituted in 10
mM Hepes pH8, 10 mM KCl, 0.1 mM EDTA, 2 mM
DTT, 400 mM NaCl, 1% Igepal and Complete™ pro-
tease inhibitors and incubated for 15 min at 4°C under
constant rotation. Cellular debris was removed by brief
centrifugation (’nucl’). Cytosolic and nuclear fractions
were combined (designated input, ‘in’). Lysates were
pre-cleared by incubation with empty glutathione
sepharose 4B beads (GE Healthcare-Amerham, NJ) or
empty Protein-G agarose beads (Roche, Germany) for
30 min to 1 hour under constant rotation at 4°C.
GST-pull down experiments
Full length Meis2a (Meis2a[1-400]), the truncated variants
Meis2a[1-190] (lacking the C-terminus including the
homeodomain, ΔHD), Meis2a[199-400] (lacking the N-ter-
minus including the MEINOX-domain, ΔMD), Meis2a
[64-400] (lacking the N-terminus but retaining the MEI-
NOX domain, ΔN) or Meis2a[1-338] (lacking the C-term-
inal transcriptional activation domain but retaining the
homeodomain, ΔC) were N-terminally fused to glu-
tathione S-transferase (GST). GST-fusion proteins were
purified following standard procedures. Immobilized
GST-fusion proteins were incubated with pre-cleared
tectal lysates for 2 hours under constant rotation at 4°C.
Following extensive washes in 10 mM Hepes pH8, 10
mM KCl, 0.1 mM EDTA, 2 mM DTT, 150 mM NaCl,
1% Igepal and Complete™, the protein complexes were
analyzed by SDS-PAGE followed by Western Blot fol-
lowing standard procedures.
Co-immunoprecipitation assay
Pre-cleared tectal lysates were incubated with polyclonal
anti-Meis2 antibody (generously provided by Dr. Arthur
Buchberg, Thomas Jefferson University Medical School,
Philadelphia) or monoclonal anti-Pax7 antibody (Devel-
opmental Study Hybridoma Bank, Iowa City, IA) over-
night at 4°C under constant rotation. Protein-G agarose
beads (Roche, Germany) were added for 1 hour at 4°C
rotating. After extensive washes, the immunoprecipitates
were separated by SDS-PAGE and analyzed by Western
Blot. For Western Blot monoclonal anti-Pax3 (mouse,
DHSB, IA; 1:5); monoclonal anti-Pax7 (mouse, DHSB,
IA; 1:5); polyclonal Otx2 (goat, R&D Systems, MN;
1:2000), or polyclonal anti-Meis2 (rabbit, A. Buchberg,
1:30.000) were used.
Electromobility shift assays
Radioactively labeled oligonucleotide probes (5’-
CGAAGCCGGCCTTGTCAGGTTGAGAA-3’) were
generated by annealing complementary single-strand oli-
gonucleotides in a solution containing 10 mM Tris
pH7.5 and 20 mM NaCl and labeled with polynucleotide
kinase (Roche, Germany) in the presence of g32P-ATP.
Binding reactions typically contained 2 μg purified GST
protein in a buffer containing 10 mM Tris HCl (pH
8.0), 150 mM KCl, 0.25 mM EDTA, 12,5% glycerol, 0.2
mM DTT, Complete™ protease inhibitor cocktail, 1 μg/
μl bovine serum albumin and 1 μg poly(dIdC) and were
incubated for 10 minutes at room temperature. 20.000
cpm of the labeled probe were added and the reaction
was incubated for further 30 minutes. For competition
experiments, a 10-fold molar excess of the non-labeled
oligomer was mixed with the radiolabeled probe prior to
addition of the proteins. DNA and DNA-protein com-
plexes were resolved on 6% non-denaturing polyacryla-
mide gels.
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